GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Raia Drogasil SA (OTCPK:RADLY) » Definitions » EV-to-FCF

RADLY (Raia Drogasil) EV-to-FCF : 174.02 (As of Dec. 14, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Raia Drogasil EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Raia Drogasil's Enterprise Value is $8,314 Mil. Raia Drogasil's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 was $48 Mil. Therefore, Raia Drogasil's EV-to-FCF for today is 174.02.

The historical rank and industry rank for Raia Drogasil's EV-to-FCF or its related term are showing as below:

RADLY' s EV-to-FCF Range Over the Past 10 Years
Min: -2628.06   Med: 64.06   Max: 2185.86
Current: 176.22

During the past 13 years, the highest EV-to-FCF of Raia Drogasil was 2185.86. The lowest was -2628.06. And the median was 64.06.

RADLY's EV-to-FCF is ranked worse than
92.86% of 406 companies
in the Healthcare Providers & Services industry
Industry Median: 18.1 vs RADLY: 176.22

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2024-12-14), Raia Drogasil's stock price is $4.15. Raia Drogasil's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was $0.111. Therefore, Raia Drogasil's PE Ratio (TTM) for today is 37.39.


Raia Drogasil EV-to-FCF Historical Data

The historical data trend for Raia Drogasil's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Raia Drogasil EV-to-FCF Chart

Raia Drogasil Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 88.37 56.90 64.01 -128.12 -167.03

Raia Drogasil Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -417.70 -167.03 -922.26 -134.15 177.99

Competitive Comparison of Raia Drogasil's EV-to-FCF

For the Pharmaceutical Retailers subindustry, Raia Drogasil's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Raia Drogasil's EV-to-FCF Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Raia Drogasil's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Raia Drogasil's EV-to-FCF falls into.



Raia Drogasil EV-to-FCF Calculation

Raia Drogasil's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=8313.763/47.774
=174.02

Raia Drogasil's current Enterprise Value is $8,314 Mil.
Raia Drogasil's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $48 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Raia Drogasil  (OTCPK:RADLY) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Raia Drogasil's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=4.15/0.111
=37.39

Raia Drogasil's share price for today is $4.15.
Raia Drogasil's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.111.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Raia Drogasil EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Raia Drogasil's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Raia Drogasil Business Description

Traded in Other Exchanges
Address
Avenue Corifeu de Azevedo Marques, 3097 Butanta, Sao Paulo, SP, BRA, 05339-9000
Raia Drogasil SA is a large retail drug store operator in Brazil. The company's stores sell branded and generic medication, over-the-counter medicine, health and beauty aids, perfumery, cosmetics, household items, and personal care products. The company also acts as a pharmacy benefit manager, performing medical purchases with prenegotiated discounts. The majority of Raia Drogasil's revenue is generated through branded drug sales, while the bulk of the remaining revenue stems from perfumery, over-the-counter drugs, and generic drugs. The company owns a variety of stakes in operational subsidiaries.

Raia Drogasil Headlines

From GuruFocus

Q2 2020 Raia Drogasil SA Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q1 2020 Raia Drogasil SA Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q4 2020 Raia Drogasil SA Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q1 2019 Raia Drogasil SA Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q3 2022 Raia Drogasil SA Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q3 2020 Raia Drogasil SA Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q3 2021 Raia Drogasil SA Earnings Call Transcript

By GuruFocus Research 02-14-2024

Raia Drogasil SA Day Transcript

By GuruFocus Research 02-14-2024

Q2 2019 Raia Drogasil SA Earnings Call Transcript

By GuruFocus Research 02-14-2024